Global /Sweden /Healthcare /Medical Distribution /LEVBIO

Level Bio AB (publ)

LEVBIO

• NGM: LEVBIO • Delayed

0.3400SEK -0.6%

0.0363 USD

As of 5 June 2026, Level Bio AB (publ) has a market cap of $2.47M USD, ranking #46685 globally and #802 in Sweden. It ranks #4129 in the Healthcare sector, and #205 in the Medical Distribution industry.

Global Rank

46685

Country Rank

802

Sector Rank

4129

Industry Rank

205

Key Stats

Market Cap

$2.47MUSD

23.26M SEK

Enterprise Value

$2.33MUSD

21.79M SEK

Revenue (TTM)

$3.56MUSD

33.51M SEK

EBITDA (TTM)

-$27.54KUSD

-258.16K SEK

Net Income (TTM)

-$305.32KUSD

-2.87M SEK

EBITDA Margin

-0.8%

Profit Margin

-8.6%

PS Ratio

0.7

PB Ratio

49.7

Company Profile

Country (HQ)

Sweden

Sector

Healthcare

Industry

Medical Distribution

CEO

Joakim Granemo open_in_new

Employees

Founded

1998

Website

levelbio.se open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-0.6%	21%	-7.6%	7.6%	-22%	13%	-22%	-49%	-80%

News

Markets

Exchange	Ticker	Price	Quotes
Nordic Growth Market (NGM) MIC: XNGM PRIMARY	LEVBIO Level Bio AB ISIN: SE0000885501 Shares Out.: Shares Outstanding: 63.399M¹ Shares Float: 46.823M² TV: TradingView: NGM: LEVBIO SA: Stock Analysis: NGM: LEVBIO YF: Yahoo Finance: LEVBIO.ST GF: Google Finance: NGM: LEVBIO BA: Barron's: LEVBIO MS: Morningstar: XNGM: LEVBIO	0.3400 SEK	TV: TradingView: NGM: LEVBIO SA: Stock Analysis: NGM: LEVBIO YF: Yahoo Finance: LEVBIO.ST GF: Google Finance: NGM: LEVBIO BA: Barron's: LEVBIO MS: Morningstar: XNGM: LEVBIO

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Level Bio AB (publ)

Level Bio AB (publ) manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.

Similar Companies

Industry: Medical Distribution (Sweden)

Name	Market Cap (USD) diff.	PE	Country
Asker Healthcare Group AB (publ) STO: ASKER	$2.93B 27.58B SEK 118K%	53.9	Sweden
Arjo AB (publ) STO: ARJO-B	$715.77M 6.73B SEK 29K%	19.2	Sweden
AcouSort AB (publ) STO: ACOU	$8.84M 83.17M SEK 258%	-	Sweden

Industry: Medical Distribution (Global)

Name	Market Cap (USD) diff.	PE	Country
McKesson Corp. NYSE: MCK	$100.76B 4M%	24.0	United States
Cencora, Inc. NYSE: COR	$60.58B 2M%	37.4	United States
Cardinal Health, Inc. NYSE: CAH	$47.73B 2M%	29.6	United States
Henry Schein, Inc. NASDAQ: HSIC	$8.47B 342K%	22.6	United States
Sinopharm Group Co. Ltd. SHEK: 1099	$7.48B 58.61B HKD 302K%	7.2	China
Galenica AG SIX: GALE	$5.3B 4.2B CHF 214K%	23.0	Switzerland

chevron_leftBack